1. Home
  2. GHG vs INO Comparison

GHG vs INO Comparison

Compare GHG & INO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

GHG

GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

HOLD

Current Price

$1.25

Market Cap

127.9M

ML Signal

HOLD

Logo Inovio Pharmaceuticals Inc.

INO

Inovio Pharmaceuticals Inc.

HOLD

Current Price

$1.19

Market Cap

114.0M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
GHG
INO
Founded
2004
1979
Country
China
United States
Employees
N/A
N/A
Industry
Hotels/Resorts
Medical/Dental Instruments
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
127.9M
114.0M
IPO Year
2017
1999

Fundamental Metrics

Financial Performance
Metric
GHG
INO
Price
$1.25
$1.19
Analyst Decision
Buy
Analyst Count
0
4
Target Price
N/A
$6.75
AVG Volume (30 Days)
27.5K
2.9M
Earning Date
05-01-2026
05-12-2026
Dividend Yield
4.10%
N/A
EPS Growth
N/A
54.18
EPS
N/A
N/A
Revenue
N/A
$42,220,086.00
Revenue This Year
$19.02
$20,156.19
Revenue Next Year
$8.26
$421.95
P/E Ratio
$5.76
N/A
Revenue Growth
N/A
19.37
52 Week Low
$1.14
$1.03
52 Week High
$2.78
$2.86

Technical Indicators

Market Signals
Indicator
GHG
INO
Relative Strength Index (RSI) 45.91 38.18
Support Level $1.16 $1.03
Resistance Level $1.34 $1.56
Average True Range (ATR) 0.06 0.08
MACD 0.01 0.00
Stochastic Oscillator 35.74 21.18

Price Performance

Historical Comparison
GHG
INO

About GHG GreenTree Hospitality Group Ltd. American depositary shares each representing one ordinary share

GreenTree Hospitality Group Ltd is a franchised hotel operator in China as franchised and managed hotels represent almost all the hotels in its hotel network. The hotel network of the company comprised approximately 4,059 hotels with nearly 302,497 rooms in China, covering all centrally administrated municipalities and cities throughout all provinces and autonomous regions in China. The company operates its hotels under GreenTree Inns, GreenTree Eastern, Gme, Gya and VX, GreenTree Alliance, Vatica, and others. The company operates solely in China and generates all its revenue from China itself.

About INO Inovio Pharmaceuticals Inc.

Inovio Pharmaceuticals Inc is a United States-based biotechnology company. The company is focused on developing and commercializing DNA medicines to help treat and protect people from HPV-associated diseases, cancer and infectious diseases. The company is engaged in gene therapy, where its immunotherapy platform consists of DNA-based immunotherapy and electroporation delivery technologies.

Share on Social Networks: